In Spain STADA has its own sales companies in Barcelona named Laboratorio STADA, S.L. and STADA Consumer Health, S.L.1).
In Spain, sales rose significantly by 17% to EUR 35.9 million in the first quarter of 2012 (1-3/2011: EUR 30.6 million).
In the Spanish generics market, characterized by sustained increased dynamic growth, STADA increased sales by 11% to EUR 32.6 million (1-3/2011: EUR 29.2 million). Generics contributed 91% to STADA’s Spanish sales in the first three months of 2012 (1-3/2011: 95%).
Sales of branded products increased by 140% in the reporting period to EUR 3.3 million (1-3/2011: EUR 1.4 million). Branded products thus contributed 9% (1-3/2011: 5%) to local STADA sales.
In financial year 2012, STADA expects, in light of further strong growth in volume of the generics market, a renewed sales increase and an operating profitability which continues to be above Group average.
| 1) | Consolidated since January 1, 2012. |